Multi-System
Also called sarcoid
Sarcoidosis is a multisystem inflammatory disorder of unknown etiology characterized by non-caseating granuloma formation in affected organs, most commonly the lungs and mediastinal lymph nodes. The disease can affect virtually any organ system including lungs, liver, heart, nervous system, skin, and eyes.
About trials for Sarcoidosis
Clinical trials are evaluating immunomodulatory therapies, TNF-alpha inhibitors, and other targeted immune therapies for sarcoidosis. The Sarcoidosis Foundation and patient organizations provide trial information and support.
Try Match Me →Can present at any age, typically ages 20-60. Higher incidence in African Americans and Northern Europeans. Women slightly more affected than men. Often diagnosed incidentally on imaging.
Clinical trials are evaluating immunomodulatory therapies, TNF-alpha inhibitors, and other targeted immune therapies for sarcoidosis. The Sarcoidosis Foundation and patient organizations provide trial information and support. Treatment decisions depend on disease extent and organ involvement; many patients with limited pulmonary disease require no treatment. Those with progressive disease may require corticosteroids or immunosuppressive agents. TNF-alpha inhibitors (infliximab, adalimumab) have shown benefit in steroid-refractory disease. Discuss with your pulmonologist or rheumatologist about trial eligibility and optimal treatment strategy based on your organ involvement.
Tuberous sclerosis is an autosomal dominant genetic disorder caused by mutations in TSC1 or TSC2 genes, resulting in dys...
Epidermolysis bullosa is a group of rare genetic blistering disorders caused by mutations affecting proteins anchoring t...
Progeria is an extremely rare genetic disorder causing rapid aging in children. A single point mutation in the LMNA gene...